Fulgent Genetics Inc. (FLGT)
17.04
-0.01 (-0.06%)
At close: Mar 31, 2025, 10:40 AM
Fulgent Genetics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY01 |
| Cash & Equivalents | 55.14M | 97.47M | 79.51M | 164.89M | 87.43M | 11.96M | 6.74M | 6.49M | 7.9M | 489K | 172K | 164.89M |
| Short-Term Investments | 202.96M | 326.68M | 773.38M | 770.65M | 344.44M | 58.25M | 30.68M | 34.88M | 38.57M | n/a | n/a | n/a |
| Long-Term Investments | n/a | 444.01M | 339.03M | 507.01M | 132.5M | 42.82M | 7.9M | 16.82M | 25.6M | n/a | n/a | n/a |
| Other Long-Term Assets | 603.81M | 22.75M | -287.39M | 141.97M | -87.97M | -36.81M | -2.7M | 4.31M | 977K | 433K | 432K | n/a |
| Receivables | 69.02M | 57.45M | 52.75M | 143.29M | 204.06M | 6.71M | 6.24M | 4M | 4.36M | 2.15M | 387K | 138.91M |
| Inventory | n/a | n/a | 4.28M | 12.21M | 16.49M | 277K | 314K | 231K | 322K | 212K | 141K | n/a |
| Other Current Assets | 26.44M | 26.25M | 44.5M | 5.96M | 3.7M | 1.33M | 1.96M | 2.17M | 697K | 286K | 10K | n/a |
| Total Current Assets | 353.57M | 507.85M | 905.63M | 1.07B | 615.73M | 76.77M | 43.37M | 45.37M | 50.83M | 2.93M | 710K | 303.81M |
| Property-Plant & Equipment | 105.55M | 95.62M | 81.35M | 62.29M | 40.2M | 5.97M | 6.45M | 7.27M | 6.23M | 2.47M | 978K | 62.29M |
| Goodwill & Intangibles | 157.03M | 165.11M | 293.67M | 86.81M | -6.83M | -1.08M | -718K | -16.95M | -25.65M | n/a | n/a | n/a |
| Total Long-Term Assets | 866.39M | 727.48M | 480.42M | 204.26M | 84.73M | 11.98M | 11.64M | 11.58M | 7.21M | 2.9M | 1.41M | 62.29M |
| Total Assets | 1.22B | 1.24B | 1.39B | 1.28B | 700.46M | 88.76M | 55.02M | 56.95M | 58.04M | 5.83M | 2.12M | 1.28B |
| Account Payables | 18.36M | 15.36M | 23.09M | 20.49M | 26.49M | 1.58M | 1.31M | 2.09M | 2.76M | 314K | 165K | n/a |
| Deferred Revenue | 27.61M | 25.57M | 14.09M | 34.38M | 26.58M | 365K | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 412K | 5.14M | 26.77M | 21.28M | 15.29M | 840K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 26.51M | 26.94M | 24.15M | 28.37M | 35.02M | 493K | 1.43M | 911K | 436K | 372K | 271K | n/a |
| Total Current Liabilities | 72.9M | 73.02M | 116.18M | 112.84M | 131.07M | 5.98M | 2.75M | 2.92M | 3.56M | 686K | 436K | n/a |
| Long-Term Debt | n/a | 10.11M | 12.17M | n/a | 1.14M | 4.51M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 11.54M | 10.95M | 15.9M | 7.53M | -177K | -2.26M | 14K | 6K | 2K | n/a | n/a | n/a |
| Total Long-Term Liabilities | 17.91M | 29.02M | 28.07M | 7.53M | 959K | 2.26M | 14K | 6K | 245K | n/a | n/a | n/a |
| Total Liabilities | 90.81M | 102.04M | 116.18M | 112.84M | 131.07M | 5.98M | 2.75M | 2.92M | 3.56M | 686K | 436K | n/a |
| Total Debt | 412K | 15.25M | 20.64M | 21.28M | 15.85M | 2.68M | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 3K | 3K | 3K | 3K | 3K | 2K | 2K | 2K | 2K | 12.32M | n/a | n/a |
| Retained Earnings | 590.47M | 633.17M | 801M | 657.6M | 150.88M | -63.43M | -63.02M | -57.66M | -55.15M | -53.16M | -10.32M | n/a |
| Comprehensive Income | -368K | 1.21M | -20.9M | -759K | 438K | 146K | -35K | -44K | -103K | -900K | -372K | n/a |
| Shareholders Equity | 1.13B | 1.14B | 1.27B | 1.17B | 569.39M | 82.78M | 52.27M | 54.03M | 54.48M | 5.15M | 1.68M | 1.17B |
| Total Investments | 202.96M | 770.69M | 785.76M | 1.28B | 476.94M | 101.07M | 32.2M | 36.81M | 38.57M | n/a | n/a | n/a |